Chesko J - Search Results

1

Characterization of antigens adsorbed to anionic PLG microparticles by XPS and TOF-SIMS.

Chesko J, Kazzaz J, Ugozzoli M, Singh M, O'Hagan DT, Madden C, Perkins M, Patel N. Chesko J, et al. J Pharm Sci. 2008 Apr;97(4):1443-53. doi: 10.1002/jps.21040. J Pharm Sci. 2008. PMID: 17724659

2

Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

Singh M, Kazzaz J, Chesko J, Soenawan E, Ugozzoli M, Giuliani M, Pizza M, Rappouli R, O'Hagan DT. Singh M, et al. Among authors: chesko j. J Pharm Sci. 2004 Feb;93(2):273-82. doi: 10.1002/jps.10538. J Pharm Sci. 2004. PMID: 14705185

3

Charged polylactide co-glycolide microparticles as antigen delivery systems.

Singh M, Kazzaz J, Ugozzoli M, Chesko J, O'Hagan DT. Singh M, et al. Among authors: chesko j. Expert Opin Biol Ther. 2004 Apr;4(4):483-91. doi: 10.1517/14712598.4.4.483. Expert Opin Biol Ther. 2004. PMID: 15102598 Review.

4

Adsorption of a novel recombinant glycoprotein from HIV (Env gp120dV2 SF162) to anionic PLG microparticles retains the structural integrity of the protein, whereas encapsulation in PLG microparticles does not.

Singh M, Chesko J, Kazzaz J, Ugozzoli M, Kan E, Srivastava I, O'Hagan DT. Singh M, et al. Among authors: chesko j. Pharm Res. 2004 Dec;21(12):2148-52. doi: 10.1007/s11095-004-7666-6. Pharm Res. 2004. PMID: 15648244

5

An investigation of the factors controlling the adsorption of protein antigens to anionic PLG microparticles.

Chesko J, Kazzaz J, Ugozzoli M, O'hagan DT, Singh M. Chesko J, et al. J Pharm Sci. 2005 Nov;94(11):2510-9. doi: 10.1002/jps.20472. J Pharm Sci. 2005. PMID: 16200615

6

Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.

Kazzaz J, Singh M, Ugozzoli M, Chesko J, Soenawan E, O'Hagan DT. Kazzaz J, et al. Among authors: chesko j. J Control Release. 2006 Feb 21;110(3):566-73. doi: 10.1016/j.jconrel.2005.10.010. Epub 2005 Dec 19. J Control Release. 2006. PMID: 16360956

7

A practical approach to the use of nanoparticles for vaccine delivery.

Wendorf J, Singh M, Chesko J, Kazzaz J, Soewanan E, Ugozzoli M, O'Hagan D. Wendorf J, et al. Among authors: chesko j. J Pharm Sci. 2006 Dec;95(12):2738-50. doi: 10.1002/jps.20728. J Pharm Sci. 2006. PMID: 16927245

8

A modified process for preparing cationic polylactide-co-glycolide microparticles with adsorbed DNA.

Singh M, Fang JH, Kazzaz J, Ugozzoli M, Chesko J, Malyala P, Dhaliwal R, Wei R, Hora M, O'Hagan D. Singh M, et al. Among authors: chesko j. Int J Pharm. 2006 Dec 11;327(1-2):1-5. doi: 10.1016/j.ijpharm.2006.07.033. Epub 2006 Jul 25. Int J Pharm. 2006. PMID: 16962267

9

The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles.

Malyala P, Chesko J, Ugozzoli M, Goodsell A, Zhou F, Vajdy M, O'Hagan DT, Singh M. Malyala P, et al. Among authors: chesko j. J Pharm Sci. 2008 Mar;97(3):1155-64. doi: 10.1002/jps.21065. J Pharm Sci. 2008. PMID: 17683059

10

A comparison of anionic nanoparticles and microparticles as vaccine delivery systems.

Wendorf J, Chesko J, Kazzaz J, Ugozzoli M, Vajdy M, O'Hagan D, Singh M. Wendorf J, et al. Among authors: chesko j. Hum Vaccin. 2008 Jan-Feb;4(1):44-9. doi: 10.4161/hv.4.1.4886. Epub 2007 Aug 15. Hum Vaccin. 2008. PMID: 18438105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters